Dr. Horacio Arruda Appointed Public Health Director for Mauricie and Centre-du-Québec

Dr. Horacio Arruda appointed as public health director for Mauricie and Centre-du-Québec

Dr. Horacio Arruda appointed as public health director for Mauricie and Centre-du-Québec Dr. Horacio Arruda has been officially appointed as the public health director for the Mauricie and Centre-du-Québec region. Following a stint as interim director since October 2025, his two-year term will formally commence on August 2, 2026, as announced by Santé Québec Mauricie-et-Centre-du-Québec … Read more

Walnuts Daily May Support Brain Development and Immune Health in Children

Feeding children aged 3 to 15 years between two and five walnuts daily may support brain growth, memory, and immune health. According to reports from Eremnews and Khaberni, this daily habit provides essential omega-3 fatty acids and vitamins that assist in cognitive development and physical growth. Nutritional Benefits for Cognitive and Physical Growth Recent nutritional … Read more

Klebsiella Pneumoniae Impairs Vascular Function via Capsule and T6SS Pathways

Researchers have identified that Klebsiella pneumoniae impairs human vascular function by inhibiting vasodilation through specific capsule and T6SS-dependent pathways. This mechanism, which increases blood pressure in animal models, relies on post-translational modification of eNOS, offering new insights into how bacterial pathogens disrupt host vascular health without necessarily causing overt sepsis. Molecular Mechanisms of Vascular Dysfunction … Read more

Individualized ASO Therapies Reduce Seizures in SCN2A-Related Epilepsy Patients

Researchers have developed individualized antisense oligonucleotide (ASO) therapies to target specific genetic variants of SCN2A-related developmental and epileptic encephalopathy. Published in Nature Medicine, the study details a precision medicine approach—using single-patient clinical trials—that successfully reduced seizures and improved neurodevelopmental outcomes in two patients without causing serious adverse events. Precision Genetic Intervention for SCN2A-DEE SCN2A-related disorders … Read more

AI Study Identifies 64 Genetic Drivers and Potential Therapies for Brain Aging

A new study published in Science Advances has utilized artificial intelligence to identify 64 genetic drivers of brain aging and pinpoint 13 potential anti-aging drugs currently undergoing clinical testing. Mapping the Genetic Landscape of Brain Aging Researchers defined brain aging by the “Brain Age Gap” (BAG), which measures the discrepancy between an individual’s predicted brain … Read more

Spouse With Dementia Increases Individual Risk Beyond Caregiving Stress

Study Scope and Methodology

A large-scale study published in the Journal of the American Medical Association (JAMA) has revealed that individuals whose spouses develop dementia face a significantly higher risk of receiving the same diagnosis themselves. According to research involving nearly 1 million married adults in Taiwan, this increased risk persists even after accounting for shared lifestyle factors, health … Read more

MIT Researchers Develop Blood Vessel-on-a-Chip to Guide Capillary Growth

Mechanical Stimulation as a Biological Cue

MIT researchers have developed a blood vessel-on-a-chip that uses mechanical stretching to precisely control the growth and branching of capillaries. By manipulating PIEZO1 ion channels, the team can direct vessel formation, offering a new, non-animal approach to engineering functional tissues for future organ transplants and disease research. Mechanical Stimulation as a Biological Cue For years, … Read more

Novo Nordisk Sues Eli Lilly for False Advertising Over Weight-Loss Drugs

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising Novo Nordisk, the Danish pharmaceutical manufacturer of Wegovy and Ozempic, has filed a lawsuit in a U.S. district court in New Jersey against its primary competitor, Eli Lilly. Allegations of Deceptive Comparative Advertising At the center of the dispute are advertisements for Eli Lilly’s weight-loss and … Read more

Swimming Reduces Disability From Chronic Back Pain, Clinical Trial Finds

A new clinical trial published on July 21, 2026, in the British Journal of Sports Medicine confirms that an eight-week program of swimming and education significantly reduces disability in adults with chronic low back pain. The study, conducted by researchers at Macquarie University, found swimming outperformed education-only approaches for long-term pain management. For years, medical … Read more

American Heart Association Confirms 400mg of Caffeine Daily Is Heart-Safe

Most adults can safely consume up to 400 milligrams of caffeine—or about five 8-ounce cups of black coffee—daily without increasing their risk of cardiovascular disease, according to a July 20, 2026, scientific statement from the American Heart Association published in the journal Circulation. For the millions of people who start their day with a cup … Read more